Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
株式のランク #18714
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
株価
$2.49
時価総額
$4.47M
変化(1日)
-4.01%
変化(1年)
678.16%
MY
取引 BioNexus Gene Lab Corporation (BGLC)

カテゴリー

BioNexus Gene Lab Corporation(BGLC)のEPS
September 2025 時点のEPS TTM: $-1.27
BioNexus Gene Lab Corporationの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-1.27です。2023年末には、EPSは$-1.53で、2022年のEPS$-0.25と増加でした。
BioNexus Gene Lab CorporationのEPS履歴(2016から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-1.27 41.11%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.77 -1,499.21%
US
$5.07 -499.21%
US
$13.17 -1,137.01%
US
$0.74 -158.17%
CN
$4.54 -457.48%
US